Hormonal Health
Menopause and HRT: What Every Woman Should Know
Haute MD Editorial Team
Menopause — the permanent cessation of menstruation, defined as 12 consecutive months without a period — typically occurs between ages 45-55, with the average age at 51 in the United States. The hormonal changes of menopause (declining estrogen and progesterone) produce symptoms ranging from hot flashes and night sweats to sleep disruption, vaginal dryness, mood changes, joint pain, cognitive changes, and accelerated bone density loss. Hormone replacement therapy (HRT) — also called menopausal hormone therapy (MHT) — addresses these symptoms by restoring estrogen (with progesterone for women with a uterus) to physiological levels.
What the current evidence actually says about HRT safety
The 2002 Women's Health Initiative (WHI) study caused widespread abandonment of HRT after reporting increased breast cancer, heart disease, stroke, and blood clot risk. Subsequent analysis revealed that the WHI studied older women (average age 63) using oral conjugated equine estrogen plus medroxyprogesterone acetate — a formulation and timing very different from modern HRT in recently menopausal women. Current evidence, including the 2023 Menopause Society position statement, indicates that for healthy women under 60 or within 10 years of menopause onset, the benefits of HRT outweigh the risks for most women. The risk profile is meaningfully different when HRT is started early versus late.
Types of HRT — transdermal vs. oral, bioidentical vs. synthetic
Transdermal estradiol (patches, gels, sprays) bypasses first-pass liver metabolism and does not increase blood clot risk the way oral estrogen does — making it the preferred delivery method. Micronized progesterone (Prometrium) does not carry the cardiovascular risks of synthetic progestins (medroxyprogesterone acetate) used in the WHI. The safest, most evidence-based modern HRT regimen is transdermal estradiol plus oral micronized progesterone. Both are FDA-approved bioidentical formulations. Compounded hormones are also bioidentical but lack FDA approval and standardized quality control.
Who HRT is and isn't appropriate for
HRT is most appropriate for healthy women under 60 or within 10 years of menopause with significant symptoms (hot flashes, night sweats, sleep disruption, vaginal dryness) or increased bone density loss. It provides the greatest benefit-to-risk ratio when started close to menopause onset (the "timing hypothesis"). HRT is generally not recommended for women with history of estrogen-receptor-positive breast cancer, unexplained vaginal bleeding, active blood clots, or recent cardiovascular events. Women with a history of breast cancer should discuss options with their oncologist — vaginal estrogen for local symptoms may be appropriate even in many breast cancer survivors.
Frequently Asked Questions
When should I start HRT?
Evidence supports the greatest benefit-to-risk ratio when HRT is started within 10 years of menopause onset or before age 60 — the "window of opportunity." Starting HRT close to the menopausal transition appears to reduce cardiovascular risk and produce the most robust bone density protection. Starting after age 60 or more than 10 years post-menopause in women with no prior HRT use carries a less favorable risk profile.
Is HRT safe after breast cancer?
Systemic HRT is generally avoided in women with estrogen-receptor-positive breast cancer. However, local/vaginal estrogen (low-dose vaginal cream, ring, or tablet for genitourinary symptoms) is considered acceptable for many breast cancer survivors by oncology societies, as systemic absorption is minimal. Women with breast cancer history should have individualized discussions with their oncologist.
How long can I take HRT?
The old guideline of "use for the shortest duration at the lowest dose" has been updated. Current guidelines support continuation of HRT as long as the woman has symptoms that respond to it and the benefit-to-risk ratio remains favorable — which for many women means indefinite use. Annual reassessment with a knowledgeable physician is recommended.
What are the most effective treatments for menopause symptoms?
For hot flashes and night sweats — HRT is the most effective treatment (70-80% reduction). Non-hormonal options include fezolinetant (Veozah, FDA-approved 2023), SSRIs/SNRIs, and gabapentin. For vaginal dryness — local estrogen or ospemifene (Osphena). For bone density — HRT plus weight-bearing exercise and calcium/vitamin D. For sleep — HRT addresses night-sweat-related disruption; CBT-I addresses insomnia component.
Get Help Now
Speak with a Haute MD Internal Medicine physician
Are you a Internal Medicine physician?
Join Haute MD Network and have your profile featured alongside these answers.
Apply for the NetworkRelated Guides
Guide · HORMONAL-HEALTH
Hormone Optimization: What It Is and Who Benefits
Hormone optimization uses evidence-based testing and therapy to restore optimal hormone levels. Learn who benefits, what's tested, and what treatment looks like.
Read GuideGuide · HORMONAL-HEALTH
Thyroid Disorders: Hypothyroidism, Hyperthyroidism, and Hashimoto's
Thyroid disorders cause fatigue, weight changes, hair loss, and mood changes. Learn how thyroid conditions are diagnosed and treated — and why the full panel matters.
Read GuideGuide · HORMONAL-HEALTH
PCOS: Causes, Symptoms, and Treatment Options
PCOS (polycystic ovary syndrome) causes irregular periods, excess androgens, and weight gain. Learn how it's diagnosed and what treatments are most effective.
Read Guide